SEC Form 4 · accession 0001193125-26-345169
KESTRA MEDICAL TECHNOLOGIES, LTD. · KMTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaseem Mahboob
Officer — Chief Financial Officer
Period of report
Aug 7, 2026
Accepted (ET)
Aug 11, 2026 · 5:56 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001877184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Aug 7, 2026 | S | 25,787 | $25.8742 | D | 61,109 | D | |
| Common SharesF3 | Aug 7, 2026 | S | 500 | $26.33 | D | 60,609 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025.
- F2The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.3100 to $26.3050. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F3The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.3150 to $26.3600. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.